EMA has recommended Ablymico and Liraglutide STADA and an oral formulation of Wegovy, potentially expanding GLP-1 treatment options for diabetes and weight management across Europe.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-backs-options-broadening-obesity-care-europe-2026a1000hbi?src=rss
Author :
Publish date : 2026-05-26 13:56:00
Copyright for syndicated content belongs to the linked Source.